Okay, let's tackle this question. The patient is overweight, 48, with increased thirst and frequent urination. Blood glucose is 180 mg/dL, which is definitely high. The past medical history mentions anaphylaxis to trimethoprim-sulfamethoxazole. So, the key here is choosing a medication for type 2 diabetes that doesn't involve sulfa drugs, since he had an allergic reaction to sulfamethoxazole.

First, the core concept is the management of type 2 diabetes in a patient with a sulfa allergy. The main drugs to consider are metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, etc. The patient's allergy to sulfamethoxazole (a sulfonamide) means we need to avoid sulfonylureas like glyburide, glipizide, etc., because they also have a sulfonamide group and could cause a cross-reaction. However, metformin is a biguanide, not a sulfa drug, so it's safe.

Looking at the options, the correct answer would be metformin. The other options might include sulfonylureas or other drugs. The patient's symptoms and lab results point to type 2 diabetes, so first-line therapy is metformin. The allergy to trimethoprim-sulfamethoxazole is a red flag to avoid sulfonylureas.

Wait, but some sources say that the cross-reactivity between sulfamethoxazole and sulfonylureas is not absolute. However, in clinical practice, it's often advised to avoid sulfonylureas in patients with a history of sulfa allergy. So metformin is the safest choice here.

The wrong options would be sulfonylureas (glyburide, glipizide), maybe thiazide diuretics (but not directly related to diabetes), or other drugs like insulin. Since the patient is overweight, metformin is also preferred as it doesn't cause weight gain.

So the correct answer is metformin. The clinical pearl here is that while cross-reactivity between sulfonamide antibiotics and sulfonylureas is possible, it's not always the case, but avoiding sulfonylureas in a patient with a sulfa allergy is a common precaution. Therefore, metformin is the best first-line agent here.

**Core Concept**
This question tests the management of type 2 diabetes in a patient with a **sulfonamide allergy**. Key considerations include avoiding **sulfonylureas** (e.g., glyburide, glipizide), which share a sulfonamide group with trimethoprim-sulfamethoxazole, to prevent cross-reactivity. **Metformin** is the first-line agent for type 2 diabetes and is structurally unrelated to sulfonamides.

**Why the Correct Answer is Right**
The patient’s symptoms (polyuria, polydipsia) and hyperglycemia (180 mg/dL) suggest **type 2 diabetes**. **Metformin** is a **biguanide** that reduces hepatic glucose production and improves insulin sensitivity. It is **not a sulfonamide** and is safe in patients with a history of allergic reactions to

✓ Correct Answer: D. Metformin